Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

DOI: https://doi.org/10.3350/cmh.2021.0202

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

Cited By 20

DOI: https://doi.org/10.3350/cmh.2020.0038

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

Cited By 9

DOI: https://doi.org/10.3350/cmh.2017.0041

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

Cited By 17

DOI: https://doi.org/10.3350/cmh.2016.0088

Case Report

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

Cited By 7

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

Original Article

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

Cited By 16

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2014;20(2):177-184. Published online June 30, 2014

Cited By 4

DOI: https://doi.org/10.3350/cmh.2014.20.2.177

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

Cited By 2

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice

Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh

Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013

Cited By 6

DOI: https://doi.org/10.3350/cmh.2013.19.1.60

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim

Clin Mol Hepatol. 2013;19(1):45-50. Published online March 25, 2013

Cited By 10

DOI: https://doi.org/10.3350/cmh.2013.19.1.45

Editorial

Noninvasive diagnostic criteria for hepatocellular carcinoma

Han Chu Lee

Clin Mol Hepatol. 2012;18(2):174-177. Published online June 26, 2012

Cited By 3

DOI: https://doi.org/10.3350/cmh.2012.18.2.174

Case Report

Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report

Jihyun An, Joo Ho Lee, Hyojeong Lee, Eunsil Yu, Dan Bi Lee, Ju Hyun Shim, Sunyoung Yoon, Yumi Lee, Soeun Park, Han Chu Lee

Clin Mol Hepatol. 2012;18(1):84-88. Published online March 22, 2012

Cited By 7

DOI: https://doi.org/10.3350/kjhep.2012.18.1.84

Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings

Joo Ho Lee, Yung Sang Lee, Pyo Nyun Kim, Beom Hee Lee, Gu-Whan Kim, Han-Wook Yoo, Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Dong Jin Suh

Clin Mol Hepatol. 2011;17(4):313-318. Published online December 26, 2011

Cited By 5

DOI: https://doi.org/10.3350/kjhep.2011.17.4.313

Original Article

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2011;17(2):113-119. Published online June 23, 2011

Cited By 21

DOI: https://doi.org/10.3350/kjhep.2011.17.2.113

Editorial

Liver function tests as indicators of metabolic syndrome

Han Chu Lee

Clin Mol Hepatol. 2011;17(1):9-11. Published online March 21, 2011

Cited By 3

DOI: https://doi.org/10.3350/kjhep.2011.17.1.9

1 |

Viewed By 7039	Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Viewed By 4146	Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Viewed By 3641	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Viewed By 2831	KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Viewed By 2065	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Cited By 44	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 33	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 30	Novel biomarkers for the management of chronic hepatitis B
Cited By 30	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Cited By 29	Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

Search